CM Management’s Gilead Sciences GILD Stock Holding History

CM Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-30,000	Closed	-$1.75M	–	89
2020 Q4	$1.75M	Buy	+30,000	New	+$1.81M	1.62%	19

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

CM Management's GILD Position: Q1 2021 in Review

CM Management sold out of Gilead Sciences (GILD) in Q1 2021, closing a stake of 30,000 shares — an estimated $1.75M sold.

CM Management first reported a position in GILD in Q4 2020 and held it in 1 quarter. The position peaked at $1.75M in Q4 2020. 1,567 funds tracked by Wall St. Rank hold GILD as of Q1 2021.

CM Management reported no remaining Gilead Sciences position as of Q1 2021 after selling out during the quarter.
CM Management sold 30,000 Gilead Sciences shares in Q1 2021, an estimated $1.75M.
CM Management first reported a position in Gilead Sciences in Q4 2020 and held it in 1 quarter.
CM Management's Gilead Sciences position peaked at $1.75M in Q4 2020.
1,567 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2021.

Based on CM Management's 13F filing for Q1 2021, filed 12 May 2021.